The Financial statement for 2017 will be published 2018-02-22.
The Interim report for third quarter will be published 2017-11-15.
BIO-Europe, the largest investment and partnering meeting in Europe, will this year take place 6-8th of November in Berlin, Germany. Sprint Bioscience will participate to meet with our global network within the pharma industry and to establish new contacts. Find out more here.
Between the 14-15th of September, Sprint Bioscience participates at the biggest Nordic Life Science Invest and Partnering meeting: NLS Days held at the Malmo Convention Center. Find out more here.
An interesting story about MTH1 from our collaboration with Bayer was published earlier this summer. Find the link to the publication here. See also Derek Lowe’s commentary in the blog “In the Pipeline”. Use this link.
Sprint Bioscience CEO Anders Åberg presented the company on Småbolagsdagen (The small enterprise day), 12 June 2017. The presentation is held in Swedish. Use this link.
Sprint Bioscience CEO Anders Åberg presented the company on Småbolagsdagen (The small enterprise day), 12 June 2017.
For those of you with a detailed interest in drug development – learn from Fredrik Rahm how the medicinal chemistry team at Sprint Bioscience uses Marvin Live to improve workflows for structure-based drug design.
Redeye has released an analysis of our company (in Swedish). You can download and read more about the analysis here.
The World Media Festival awards recognize excellence in modern communications media, and are acknowledged internationally as symbols of the highest production standards in modern communication. Award winners are among the leaders in their profession. Sprint Bioscience submitted the video “Fragments of Hope”. The video describes the company and drug development and at the gala, held…